My Watchlist Items

      No Watchlist
Leap Therapeutics, Inc. (LPTX)
   1.14   -0.02999997(-2.5641003%)
TitleNamePayCurrency PayGenderYear BornTitle Since
Senior Research Fellow Dr. Walter Newman N/A USD N/A N/A
Vice President & Head of Translational Medicine Dr. Jason S. Baum Ph.D. N/A USD N/A N/A
Vice President and Head of Regulatory Affairs & Quality Ms. Christine M. Granfield N/A USD female N/A N/A
Chief Manufacturing Officer Mr. Mark O'Mahony N/A USD male N/A N/A
Chief Medical Officer Dr. Cynthia A. Sirard 617040 USD 1970 N/A
Chief Operating Officer Mr. Augustine J. Lawlor 609510 USD male 1958 N/A
Chief Financial Officer, Gen. Counsel, Treasurer & Sec., Pres, Chief Executive Officer & Director Mr. Douglas E. Onsi J.D. 865240 USD male 1969 N/A
SymbolDateRatingRating Score Rating Details
LPTX 20 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 19 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 18 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 17 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 16 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 13 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 12 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 11 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 10 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 9 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 6 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 5 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 4 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 3 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 29 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 28 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 27 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 26 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 25 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 22 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 21 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 20 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 19 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 18 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 15 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 14 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 13 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 12 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 11 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 8 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 7 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 6 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 5 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 4 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 1 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 31 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 30 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 29 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 28 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 25 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 24 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 23 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 22 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 21 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 18 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 17 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 16 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 15 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 14 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 11 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 10 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 9 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 8 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 7 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 4 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 3 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 2 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 1 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 28 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 25 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 24 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 23 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 22 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 18 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 17 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 16 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 15 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 14 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 11 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 10 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 9 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 8 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 7 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 5 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 4 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 3 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 2 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 1 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 31 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 28 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 27 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 26 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 25 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 24 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 21 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 20 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 19 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 18 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 14 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 13 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 12 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 11 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 10 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 7 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 6 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 5 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 4 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 3 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 31 December, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
LPTX 30 December, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
GYON TECHNOLOGIES CAPITAL MANAGEMENT, LP 21659 31 March, 2022 21659
ARTAL GROUP S.A. 4000000 31 March, 2022 0
PERSONAL CFO SOLUTIONS, LLC 63165 31 March, 2022 -8000
D.A. DAVIDSON & CO. 13500 31 March, 2022 0
BAYSTATE WEALTH MANAGEMENT LLC 15385 31 March, 2022 0
PLATINUM INVESTMENT MANAGEMENT LTD 1327952 31 March, 2022 0
GEODE CAPITAL MANAGEMENT, LLC 608765 31 March, 2022 43282
DIMENSIONAL FUND ADVISORS LP 146347 31 March, 2022 -21924
KEY CLIENT FIDUCIARY ADVISORS, LLC 707830 31 March, 2022 198850
BANK OF NEW YORK MELLON CORP 36974 31 March, 2022 0
VALEO FINANCIAL ADVISORS, LLC 15635 31 March, 2022 0
BLACKROCK INC. 1198188 31 March, 2022 14079
BAILARD, INC. 34700 31 March, 2022 -21600
SILVERARC CAPITAL MANAGEMENT, LLC 1032163 31 March, 2022 18499
ADVISOR GROUP HOLDINGS, INC. 50925 31 March, 2022 0
DONALDSON CAPITAL MANAGEMENT, LLC 12200 31 March, 2022 0
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) 9736 31 March, 2022 9736
HIGH NET WORTH ADVISORY GROUP LLC 1000 31 March, 2022 0
PRIVATE ADVISOR GROUP, LLC 22500 31 March, 2022 11500
GILMAN HILL ASSET MANAGEMENT, LLC 12500 31 March, 2022 0
DLD ASSET MANAGEMENT, LP 250000 31 March, 2022 -120000
SG AMERICAS SECURITIES, LLC 37877 31 March, 2022 37877
QUBE RESEARCH & TECHNOLOGIES LTD 36246 31 March, 2022 36246
COASTAL BRIDGE ADVISORS, LLC 22000 31 March, 2022 0
TOWER RESEARCH CAPITAL LLC (TRC) 3117 31 March, 2022 3117
KEYSTONE FINANCIAL GROUP 17120 31 March, 2022 0
JPMORGAN CHASE & CO 10542 31 March, 2022 2756
TCI WEALTH ADVISORS, INC. 400 31 March, 2022 -100
ACT CAPITAL MANAGEMENT, LLC 265000 31 March, 2022 40000
MCADAM, LLC 48885 31 March, 2022 16101
RAYMOND JAMES & ASSOCIATES 43545 31 March, 2022 8373
M28 CAPITAL MANAGEMENT LP 2664400 31 March, 2022 1664400
CNB BANK 3000 31 March, 2022 1000
NORTHERN TRUST CORP 111122 31 March, 2022 0
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 32000 31 March, 2022 0
US BANCORP \DE\ 6100 31 March, 2022 0
MORGAN STANLEY 699234 31 March, 2022 399285
CITIGROUP INC 5012 31 March, 2022 2315
COMMUNITY TRUST & INVESTMENT CO 13650 31 March, 2022 0
JANNEY MONTGOMERY SCOTT LLC 25000 31 March, 2022 0
VANGUARD GROUP INC 3256331 31 March, 2022 137159
INTEGRATED WEALTH CONCEPTS LLC 15000 31 March, 2022 15000
FMR LLC 1000 31 March, 2022 1000
GROUP ONE TRADING, L.P. 40417 31 March, 2022 29095
TOMPKINS FINANCIAL CORP 1205 31 March, 2022 1205
MILLENNIUM MANAGEMENT LLC 2040384 31 December, 2021 1993770
ATOM INVESTORS LP 152967 31 December, 2021 152967
BAKER BROS. ADVISORS LP 559705 31 December, 2021 0
BANK OF AMERICA CORP /DE/ 837078 31 December, 2021 104067
PERCEPTIVE ADVISORS LLC 8476496 31 December, 2021 0
BNP PARIBAS ARBITRAGE, SA 43947 31 December, 2021 43947
BRIDGEWAY CAPITAL MANAGEMENT INC 167101 31 December, 2021 -80000
JANNEY MONTGOMERY SCOTT LLC 25000 31 December, 2021 0
CAPTRUST FINANCIAL ADVISORS 4000 31 December, 2021 4000
CUBIST SYSTEMATIC STRATEGIES, LLC 169589 31 December, 2021 169589
SILVERARC CAPITAL MANAGEMENT, LLC 1013664 31 December, 2021 393664
GHOST TREE CAPITAL, LLC 1350000 31 December, 2021 -300000
GOLDEN STATE EQUITY PARTNERS 11650 31 December, 2021 11650
GOLDMAN SACHS GROUP INC 151500 31 December, 2021 151500
ACT CAPITAL MANAGEMENT, LLC 225000 31 December, 2021 70000
HEALTHCOR MANAGEMENT, L.P. 1066689 31 December, 2021 -133311
J. GOLDMAN & CO LP 540000 31 December, 2021 540000
LPL FINANCIAL LLC 22825 31 December, 2021 0
MARSHALL WACE, LLP 920241 31 December, 2021 920241
ALLY BRIDGE GROUP (NY) LLC 1815000 31 December, 2021 615000
GROUP ONE TRADING, L.P. 11322 31 December, 2021 11322
ARTAL GROUP S.A. 4000000 31 December, 2021 0
PALOMA PARTNERS MANAGEMENT CO 20302 31 December, 2021 20302
PLATINUM INVESTMENT MANAGEMENT LTD 1327952 31 December, 2021 0
ROCK SPRINGS CAPITAL MANAGEMENT LP 3520570 31 December, 2021 12300
SCHONFELD STRATEGIC ADVISORS LLC 35300 31 December, 2021 0
SIO CAPITAL MANAGEMENT, LLC 440000 31 December, 2021 0
STATE STREET CORP 132600 31 December, 2021 0
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 11814 31 December, 2021 11814
TANG CAPITAL MANAGEMENT LLC 2500000 31 December, 2021 0
TWO SIGMA ADVISERS, LLC 1526600 31 December, 2021 1133800
TWO SIGMA INVESTMENTS LLC 1517045 31 December, 2021 1217445
DLD ASSET MANAGEMENT, LP 370000 31 December, 2021 370000
UBS GROUP AG 9891 31 December, 2021 -3624
CITADEL ADVISORS LLC 124011 31 December, 2021 101590
SUSQUEHANNA INTERNATIONAL GROUP, LLP 152661 31 December, 2021 152661
M28 CAPITAL MANAGEMENT LP 1000000 31 December, 2021 1000000
HolderSharesDate ReportedWeight Percent
BOOTHBAY FUND MANAGEMENT, LLC 24767 31 March, 2022 N/A
DIMENSIONAL FUND ADVISORS LP 146347 31 March, 2022 N/A
SPHERA FUNDS MANAGEMENT LTD. 800000 31 December, 2020 N/A
iShares Micro-Cap ETF 55287 31 August, 2020 0.01
Vanguard Total Stock Market Index Fund 1205120 31 August, 2020 N/A
Vanguard Balanced Index Fund 36243 31 July, 2020 N/A
Vanguard US Equity Index Fund 13834 31 July, 2020 N/A
Vanguard Extended Market Index Fund 199863 31 July, 2020 N/A
Fidelity Extended Market Index Fund 59536 31 July, 2020 N/A
Vanguard Institutional Total Stock Market Index Fund 52185 31 July, 2020 N/A
Fidelity Total Market Index Fund 42530 31 July, 2020 N/A
Fidelity NASDAQ Composite Index Fund 28305 31 July, 2020 N/A
Fidelity Series Total Market Index Fund 14914 31 July, 2020 N/A
WEALTHGATE Biotech Aggressive Fund 16660 30 June, 2020 0.62
VALIC Co I Small Cap Fund 29500 30 June, 2020 0.02
Bridgeway Ultra-Small Company Market Fund 103500 30 June, 2020 0.15
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
LPTX 31 January, 2022 0001013473 55000 0001509745 CAVANAUGH JAMES H A 4 55000 Stock Option (Right to Buy) View
LPTX 31 January, 2022 0001808556 225000 0001509745 O'Mahony John Mark A 4 225000 Restricted Stock Units View
LPTX 31 January, 2022 0001357777 55000 0001509745 Mashiach Nissim A 4 55000 Stock Option (Right to Buy) View
LPTX 31 January, 2022 0001273806 55000 0001509745 LI WILLIAM A 4 55000 Stock Option (Right to Buy) View
LPTX 31 January, 2022 0001262327 225000 0001509745 LAWLOR AUGUSTINE A 4 225000 Restricted Stock Units View
LPTX 31 January, 2022 0001276128 55000 0001509745 LOSCALZO JOSEPH A 4 55000 Stock Option (Right to Buy) View
LPTX 31 January, 2022 0001808408 225000 0001509745 Sirard Cynthia A 4 225000 Restricted Stock Units View
LPTX 31 January, 2022 0001822190 225000 0001509745 Granfield Christine A 4 225000 Restricted Stock Units View
LPTX 31 January, 2022 0001270185 325000 0001509745 ONSI DOUGLAS E A 4 325000 Restricted Stock Units View
LPTX 31 January, 2022 0001761030 55000 0001509745 Bertagnolli Monica A 4 55000 Stock Option (Right to Buy) View
LPTX 31 January, 2022 0001574218 60000 0001509745 Dietz Thomas John A 4 60000 Stock Option (Right to Buy) View
LPTX 31 January, 2022 0001262326 225000 0001509745 Mirabelli Christopher A 4 225000 Restricted Stock Units View
LPTX 24 September, 2021 0001651308 7348437 0001509745 BeiGene, Ltd. A 4 2543800 Common Stock View
LPTX 24 September, 2021 0001224962 3508771 0001509745 PERCEPTIVE ADVISORS LLC A 4 3508771 Warrants (right to buy) View
LPTX 8 September, 2021 0001761030 65000 0001509745 Bertagnolli Monica A 4 65000 Stock Option (Right to Buy) View
LPTX 8 September, 2021 0001761030 16150 0001509745 Bertagnolli Monica A 4 16150 Stock Option (Right to Buy) View
LPTX 26 May, 2021 0001262326 30000 0001509745 Mirabelli Christopher A 4 30000 Stock Option (Right to Buy) View
LPTX 26 May, 2021 0001262327 30000 0001509745 LAWLOR AUGUSTINE A 4 30000 Employee Stock Option (Right to Buy) View
LPTX 26 May, 2021 0001808556 30000 0001509745 O'Mahony John Mark A 4 30000 Employee Stock Option (Right to Buy) View
LPTX 26 May, 2021 0001822190 30000 0001509745 Granfield Christine A 4 30000 Employee Stock Option (Right to Buy) View
LPTX 26 May, 2021 0001270185 30000 0001509745 ONSI DOUGLAS E A 4 30000 Employee Stock Option (Right to Buy) View
LPTX 26 May, 2021 0001808408 30000 0001509745 Sirard Cynthia A 4 30000 Employee Stock Option (Right to Buy) View
LPTX 9 February, 2021 0001490245 0 0001509745 HealthCare Ventures IX, L.P. D 4 571428 Warrant (Right to Buy) View
LPTX 9 February, 2021 0001262327 0 0001509745 LAWLOR AUGUSTINE D 4 571428 Warrant (Right to Buy) View
LPTX 9 February, 2021 0001262327 11544 0001509745 LAWLOR AUGUSTINE A 4 11544 Warrant (Right to Buy) View
LPTX 9 February, 2021 0001262326 11544 0001509745 Mirabelli Christopher A 4 11544 Warrant (Right to Buy) View
LPTX 9 February, 2021 0001262326 0 0001509745 Mirabelli Christopher D 4 571428 Warrant (Right to Buy) View
LPTX 9 February, 2021 0001270185 0 0001509745 ONSI DOUGLAS E D 4 571428 Warrant (Right to Buy) View
LPTX 9 February, 2021 0001270185 11544 0001509745 ONSI DOUGLAS E A 4 11544 Warrant (Right to Buy) View
LPTX 9 February, 2021 0001013473 1154 0001509745 CAVANAUGH JAMES H A 4 1154 Warrant (Right to Buy) View
LPTX 26 January, 2021 0001270185 75000 0001509745 ONSI DOUGLAS E A 4 75000 Restricted Stock Units View
LPTX 26 January, 2021 0001270185 175000 0001509745 ONSI DOUGLAS E A 4 175000 Employee Stock Option (Right to Buy) View
LPTX 26 January, 2021 0001822190 50000 0001509745 Granfield Christine A 4 50000 Employee Stock Option (Right to Buy) View
LPTX 26 January, 2021 0001808408 50000 0001509745 Sirard Cynthia A 4 50000 Restricted Stock Units View
LPTX 26 January, 2021 0001808408 150000 0001509745 Sirard Cynthia A 4 150000 Employee Stock Option (Right to Buy) View
LPTX 26 January, 2021 0001808556 50000 0001509745 O'Mahony John Mark A 4 50000 Restricted Stock Units View
LPTX 26 January, 2021 0001262326 150000 0001509745 Mirabelli Christopher A 4 150000 Employee Stock Option (Right to Buy) View
LPTX 26 January, 2021 0001262326 50000 0001509745 Mirabelli Christopher A 4 50000 Restricted Stock Units View
LPTX 26 January, 2021 0001262327 150000 0001509745 LAWLOR AUGUSTINE A 4 150000 Employee Stock Option (Right to Buy) View
LPTX 26 January, 2021 0001262327 50000 0001509745 LAWLOR AUGUSTINE A 4 50000 Restricted Stock Units View
LPTX 26 January, 2021 0001808556 150000 0001509745 O'Mahony John Mark A 4 150000 Employee Stock Option (Right to Buy) View
LPTX 4 January, 2021 0001276128 32300 0001509745 LOSCALZO JOSEPH A 4 32300 Stock Option (Right to Buy) View
LPTX 4 January, 2021 0001273806 32300 0001509745 LI WILLIAM A 4 32300 Stock Option (Right to Buy) View
LPTX 4 January, 2021 0001357777 32300 0001509745 Mashiach Nissim A 4 32300 Stock Option (Right to Buy) View
LPTX 4 January, 2021 0001013473 32300 0001509745 CAVANAUGH JAMES H A 4 32300 Stock Option (Right to Buy) View
LPTX 4 January, 2021 0001574218 37300 0001509745 Dietz Thomas John A 4 37300 Stock Option (Right to Buy) View
LPTX 28 December, 2020 0001358990 0 0001509745 HealthCare Ventures VIII, L.P. D 4 2618406 Common Stock View
LPTX 10 August, 2020 0001276128 10000 0001509745 LOSCALZO JOSEPH A 4 10000 Stock Option (Right to Buy) View
LPTX 10 August, 2020 0001013473 10000 0001509745 CAVANAUGH JAMES H A 4 10000 Stock Option (Right to Buy) View
LPTX 10 August, 2020 0001808556 75000 0001509745 O'Mahony John Mark A 4 75000 Stock Option (Right to Buy) View
LPTX 10 August, 2020 0001808408 75000 0001509745 Sirard Cynthia A 4 75000 Stock Option (Right to Buy) View
LPTX 10 August, 2020 0001273806 10000 0001509745 LI WILLIAM A 4 10000 Stock Option (Right to Buy) View
LPTX 10 August, 2020 0001574218 12500 0001509745 Dietz Thomas John A 4 12500 Stock Option (Right to Buy) View
LPTX 10 August, 2020 0001262327 75000 0001509745 LAWLOR AUGUSTINE A 4 75000 Stock Option (Right to Buy) View
LPTX 10 August, 2020 0001262326 75000 0001509745 Mirabelli Christopher A 4 75000 Stock Option (Right to Buy) View
LPTX 10 August, 2020 0001270185 75000 0001509745 ONSI DOUGLAS E A 4 75000 Employee Stock Option (Right to Buy) View
LPTX 10 August, 2020 0001357777 10000 0001509745 Mashiach Nissim A 4 10000 Stock Option (Right to Buy) View
LPTX 22 June, 2020 0001224962 8476496 0001509745 PERCEPTIVE ADVISORS LLC A 4 1750000 Common Stock View
LPTX 9 April, 2020 0001808556 50000 0001509745 O'Mahony John Mark A 4 50000 Stock Option (Right to Buy) View
LPTX 9 April, 2020 0001262327 50000 0001509745 LAWLOR AUGUSTINE A 4 50000 Stock Option (Right to Buy) View
LPTX 9 April, 2020 0001808408 50000 0001509745 Sirard Cynthia A 4 50000 Stock Option (Right to Buy) View
LPTX 9 April, 2020 0001357777 10000 0001509745 Mashiach Nissim A 4 10000 Stock Option (Right to Buy) View
LPTX 9 April, 2020 0001574218 12500 0001509745 Dietz Thomas John A 4 12500 Stock Option (Right to Buy) View
LPTX 9 April, 2020 0001262326 50000 0001509745 Mirabelli Christopher A 4 50000 Stock Option (Right to Buy) View
LPTX 9 April, 2020 0001276128 10000 0001509745 LOSCALZO JOSEPH A 4 10000 Stock Option (Right to Buy) View
LPTX 9 April, 2020 0001273806 10000 0001509745 LI WILLIAM A 4 10000 Stock Option (Right to Buy) View
LPTX 9 April, 2020 0001013473 10000 0001509745 CAVANAUGH JAMES H A 4 10000 Stock Option (Right to Buy) View
LPTX 17 March, 2020 0001270185 500000 0001509745 ONSI DOUGLAS E A 4 500000 Employee Stock Option (Right to Buy) View
LPTX 17 March, 2020 0001270185 660606 0001509745 ONSI DOUGLAS E A 4 660606 Restricted Stock Units View
LPTX 2 March, 2020 0001013473 20000 0001509745 CAVANAUGH JAMES H A 4 20000 Stock Option (Right to Buy) View
LPTX 2 March, 2020 0001276128 20000 0001509745 LOSCALZO JOSEPH A 4 20000 Stock Option (Right to Buy) View
LPTX 2 March, 2020 0001013469 20000 0001509745 LITTLECHILD JOHN W A 4 20000 Stock Option (Right to Buy) View
LPTX 2 March, 2020 0001273806 20000 0001509745 LI WILLIAM A 4 20000 Stock Option (Right to Buy) View
LPTX 2 March, 2020 0001357777 20000 0001509745 Mashiach Nissim A 4 20000 Stock Option (Right to Buy) View
LPTX 2 March, 2020 0001574218 25000 0001509745 Dietz Thomas John A 4 25000 Stock Option (Right to Buy) View
LPTX 11 June, 2019 0001013469 10000 0001509745 LITTLECHILD JOHN W A 4 10000 Stock Option (Right to Buy) View
LPTX 11 June, 2019 0001357777 10000 0001509745 Mashiach Nissim A 4 10000 Stock Option (Right to Buy) View
LPTX 11 June, 2019 0001574218 15000 0001509745 Dietz Thomas John A 4 15000 Stock Option (Right to Buy) View
LPTX 11 June, 2019 0001270185 200000 0001509745 ONSI DOUGLAS E A 4 200000 Employee Stock Option (Right to Buy) View
LPTX 11 June, 2019 0001273806 10000 0001509745 LI WILLIAM A 4 10000 Stock Option (Right to Buy) View
LPTX 11 June, 2019 0001262327 200000 0001509745 LAWLOR AUGUSTINE A 4 200000 Employee Stock Option (Right to Buy) View
LPTX 11 June, 2019 0001276128 10000 0001509745 LOSCALZO JOSEPH A 4 10000 Stock Option (Right to Buy) View
LPTX 11 June, 2019 0001013473 10000 0001509745 CAVANAUGH JAMES H A 4 10000 Stock Option (Right to Buy) View
LPTX 11 June, 2019 0001262326 200000 0001509745 Mirabelli Christopher A 4 200000 Employee Stock Option (Right to Buy) View
LPTX 5 February, 2019 0001270185 592797 0001509745 ONSI DOUGLAS E A 4 571428 Warrant (Right to Buy) View
LPTX 5 February, 2019 0001262326 592797 0001509745 Mirabelli Christopher A 4 571428 Warrant (Right to Buy) View
LPTX 5 February, 2019 0001270185 4114804 0001509745 ONSI DOUGLAS E A 4 571428 Common Stock View
LPTX 5 February, 2019 0001490245 4144804 0001509745 HealthCare Ventures IX, L.P. A 4 571428 Common Stock View
LPTX 5 February, 2019 0001490245 571428 0001509745 HealthCare Ventures IX, L.P. A 4 571428 Warrant (Right to Buy) View
LPTX 5 February, 2019 0001262326 4114804 0001509745 Mirabelli Christopher A 4 571428 Common Stock View
LPTX 5 February, 2019 0001262327 4114804 0001509745 LAWLOR AUGUSTINE A 4 571428 Common Stock View
LPTX 5 February, 2019 0001262327 592797 0001509745 LAWLOR AUGUSTINE A 4 571428 Warrant (Right to Buy) View
LPTX 1 January, 2019 0001262327 50000 0001509745 LAWLOR AUGUSTINE A 4 50000 Employee Stock Option (Right to Buy) View
LPTX 1 January, 2019 0001262326 50000 0001509745 Mirabelli Christopher A 4 50000 Employee Stock Option (Right to Buy) View
LPTX 1 January, 2019 0001013469 7500 0001509745 LITTLECHILD JOHN W A 4 7500 Stock Option (Right to Buy) View
LPTX 1 January, 2019 0001273806 7500 0001509745 LI WILLIAM A 4 7500 Stock Option (Right to Buy) View
LPTX 1 January, 2019 0001357777 7500 0001509745 Mashiach Nissim A 4 7500 Stock Option (Right to Buy) View
LPTX 1 January, 2019 0001276128 7500 0001509745 LOSCALZO JOSEPH A 4 7500 Stock Option (Right to Buy) View
LPTX 1 January, 2019 0001574218 9375 0001509745 Dietz Thomas John A 4 9375 Stock Option (Right to Buy) View
LPTX 1 January, 2019 0001013473 7500 0001509745 CAVANAUGH JAMES H A 4 7500 Stock Option (Right to Buy) View
SymbolDatePeriodDownload XLSX File
LPTX 2021 FY Download XLSX File
LPTX 2020 FY Download XLSX File
LPTX 2019 FY Download XLSX File
LPTX 2018 FY Download XLSX File
LPTX 2017 FY Download XLSX File
LPTX 2021 Q3 Download XLSX File
LPTX 2021 Q1 Download XLSX File
LPTX 2021 Q2 Download XLSX File
LPTX 2021 Q4 Download XLSX File
LPTX 2020 Q4 Download XLSX File
LPTX 2020 Q1 Download XLSX File
LPTX 2020 Q2 Download XLSX File
LPTX 2020 Q3 Download XLSX File
LPTX 2019 Q4 Download XLSX File
LPTX 2019 Q1 Download XLSX File
LPTX 2019 Q2 Download XLSX File
LPTX 2019 Q3 Download XLSX File
LPTX 2018 Q3 Download XLSX File
LPTX 2018 Q1 Download XLSX File
LPTX 2018 Q2 Download XLSX File
LPTX 2018 Q4 Download XLSX File
LPTX 2017 Q3 Download XLSX File
LPTX 2017 Q1 Download XLSX File
LPTX 2017 Q2 Download XLSX File
LPTX 2017 Q4 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
13 May, 2022 LPTX -0.09 -0.09 bmo 0 0
11 March, 2022 LPTX -0.1 -0.1 bmo 375 190000
12 November, 2021 LPTX -0.14 -0.14 bmo 375000 310000
13 August, 2021 LPTX -0.12 -0.12 bmo 375000 375000
14 May, 2021 LPTX -0.12 -0.12 bmo 375000 340909
12 March, 2021 LPTX -0.09 -0.09 bmo 375000 0
13 August, 2020 LPTX -0.12 -0.12 bmo 375000 562500
14 May, 2020 LPTX -0.55 -0.55 bmo 375000 270702
16 March, 2020 LPTX -0.33 -0.33 bmo 0 0
14 November, 2019 LPTX -0.33 -0.33 bmo 0 0
9 August, 2019 LPTX -0.37 -0.37 bmo 0 0
15 May, 2019 LPTX -0.47 -0.47 bmo 0 0
1 April, 2019 LPTX 0.12 0.12 bmo 0 0
9 November, 2018 LPTX -0.45 -0.45 bmo 0 0
8 August, 2018 LPTX -0.5 -0.5 bmo 0 0
11 May, 2018 LPTX -0.85 -0.85 bmo 0 0
23 February, 2018 LPTX -0.65 -0.65 bmo 0 0
13 November, 2017 LPTX -0.73 -0.73 bmo 0 0
11 August, 2017 LPTX -0.74 -0.74 bmo 0 0
28 June, 2017 LPTX -1.39 -1.39 bmo 0 0
31 March, 2017 LPTX -0.58 -0.58 bmo 0 0
23 November, 2016 LPTX bmo 0 0

Company Profile

Company Name Leap Therapeutics, Inc.
Symbol LPTX
Currency USD
Price 1.14
Exchange Name NASDAQ Global Market (NASDAQ)
Industry Biotechnology
CEO Dr. Christopher Mirabelli
Sector Healthcare
Country US
Full Time Employees 36
Phone 16172524343
Address 47 Thorndike St Ste B1-1
City Cambridge
State MASSACHUSETTS
Zip 02141
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
>

FREE

Get the most important news and analyses for Free.

Thank you for subscribing.

Something went wrong.